ACON vs. FRES, ANPC, OPGN, AMS, CNTG, PMD, REUN, NURO, CYCC, and AGLE
Should you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include Fresh2 Group (FRES), Fresh2 Group (ANPC), OpGen (OPGN), American Shared Hospital Services (AMS), Centogene (CNTG), Psychemedics (PMD), Reunion Neuroscience (REUN), NeuroMetrix (NURO), Cyclacel Pharmaceuticals (CYCC), and Aeglea BioTherapeutics (AGLE). These companies are all part of the "medical" sector.
Aclarion vs.
Aclarion (NASDAQ:ACON) and Fresh2 Group (NASDAQ:FRES) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, community ranking, analyst recommendations and profitability.
Aclarion received 1 more outperform votes than Fresh2 Group when rated by MarketBeat users.
Aclarion currently has a consensus target price of $3.00, indicating a potential upside of 191.26%. Given Aclarion's higher probable upside, research analysts clearly believe Aclarion is more favorable than Fresh2 Group.
2.0% of Aclarion shares are held by institutional investors. Comparatively, 45.8% of Fresh2 Group shares are held by institutional investors. 22.1% of Aclarion shares are held by company insiders. Comparatively, 26.2% of Fresh2 Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Aclarion had 2 more articles in the media than Fresh2 Group. MarketBeat recorded 2 mentions for Aclarion and 0 mentions for Fresh2 Group. Aclarion's average media sentiment score of 0.89 beat Fresh2 Group's score of 0.00 indicating that Aclarion is being referred to more favorably in the media.
Fresh2 Group has a net margin of 0.00% compared to Aclarion's net margin of -12,583.55%.
Aclarion has higher earnings, but lower revenue than Fresh2 Group.
Summary
Aclarion beats Fresh2 Group on 7 of the 12 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ACON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Aclarion Competitors List
Related Companies and Tools